Winton Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Buy |
+102,668
| New | +$2.45M | 0.13% | 214 |
|
|
2024
Q3 | – | Sell |
-95,266
| Closed | -$2.73M | – | 741 |
|
|
2024
Q2 | $2.73M | Buy |
+95,266
| New | +$2.73M | 0.18% | 102 |
|
|
2023
Q1 | – | Sell |
-13,173
| Closed | -$509K | – | 1044 |
|
|
2022
Q4 | $509K | Buy |
+13,173
| New | +$509K | 0.03% | 625 |
|
|
2021
Q4 | – | Sell |
-7,437
| Closed | -$416K | – | 1295 |
|
|
2021
Q3 | $416K | Sell |
7,437
-3,058
| -29% | -$171K | 0.02% | 951 |
|
|
2021
Q2 | $637K | Sell |
10,495
-3,080
| -23% | -$187K | 0.03% | 785 |
|
|
2021
Q1 | $951K | Buy |
13,575
+2,810
| +26% | +$197K | 0.05% | 498 |
|
|
2020
Q4 | $644K | Sell |
10,765
-6,632
| -38% | -$397K | 0.05% | 657 |
|
|
2020
Q3 | $1.05M | Sell |
17,397
-65,405
| -79% | -$3.93M | 0.03% | 806 |
|
|
2020
Q2 | $4.35M | Sell |
82,802
-61,022
| -42% | -$3.2M | 0.11% | 274 |
|
|
2020
Q1 | $4.82M | Sell |
143,824
-17,810
| -11% | -$597K | 0.13% | 265 |
|
|
2019
Q4 | $7.32M | Buy |
161,634
+117,039
| +262% | +$5.3M | 0.1% | 340 |
|
|
2019
Q3 | $1.7M | Buy |
+44,595
| New | +$1.7M | 0.02% | 633 |
|